These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current good manufacturing practices for PET drug products in the United States. Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213 [No Abstract] [Full Text] [Related]
5. Proposed current good manufacturing practice and supplemental regulations. Korun FD Bull Parenter Drug Assoc; 1976; 30(3):139-42. PubMed ID: 1268432 [No Abstract] [Full Text] [Related]
6. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related]
8. [Round table on the "norms for good drug compounding"]. Boll Chim Farm; 1970 Nov; 109(11):635-52. PubMed ID: 5515584 [No Abstract] [Full Text] [Related]
9. Drug product quality. Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595 [No Abstract] [Full Text] [Related]
10. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
11. Pharmaceutical controls for drug availability. Bethel RF Med Serv J Can; 1967 Mar; 23(3):337-45. PubMed ID: 6061040 [No Abstract] [Full Text] [Related]
12. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Requirements of the iks (intercantonal control agency) guide lines]. Zinn W Pharm Acta Helv; 1973 Jan; 48(1):1-21. PubMed ID: 4696262 [No Abstract] [Full Text] [Related]
13. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in medium-size plants]. Schlumpf R Pharm Acta Helv; 1973 Jan; 48(1):22-36. PubMed ID: 4696263 [No Abstract] [Full Text] [Related]
14. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in larger plants]. Büchler W Pharm Acta Helv; 1973 Jan; 48(1):11-21. PubMed ID: 4696261 [No Abstract] [Full Text] [Related]
15. Panel discussion: in process control and inspection for quality assurance. 3. Brofazi FR Bull Parenter Drug Assoc; 1968; 22(2):90-6. PubMed ID: 5649572 [No Abstract] [Full Text] [Related]
16. Quality assurance and parenterals. Beall D Bull Parenter Drug Assoc; 1970; 24(4):176-82. PubMed ID: 5431585 [No Abstract] [Full Text] [Related]
17. When does compounding become manufacturing? Gushee J J Am Vet Med Assoc; 1994 Jul; 205(2):235-6. PubMed ID: 7928585 [No Abstract] [Full Text] [Related]
18. Contemporary pharmaceutical compounding. Allen LV Ann Pharmacother; 2003 Oct; 37(10):1526-8. PubMed ID: 14519042 [No Abstract] [Full Text] [Related]
19. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036 [TBL] [Abstract][Full Text] [Related]
20. [Quality control in the pharmaceutical industry]. Sloot HA Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061 [No Abstract] [Full Text] [Related] [Next] [New Search]